You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
News items for the week of Sept. 28, 2020
Both RT-PCR tests are for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B from throat swab samples.
BGI will have a chance to depose up to nine inventors of patents assigned to Illumina as part of a lawsuit over IP related to sequencing-by-synthesis chemistry.
Sweden's public health authority says BGI's COVID-19 test returned thousands of false positive results, according to Reuters.
News items for the week of August 10, 2020.
The US Commerce Department has placed two BGI Group subsidiaries on a list of entities it suspects of human rights violations, allegations the company denies, Reuters reports.
A US District Court will prevent BGI from distributing and promoting certain sequencing instruments that allegedly infringe Illumina patents.
To enable the use of saliva in addition to other types of samples, Sysmex requested a change to a marketing approval it obtained in March.
Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.
BGI will establish six so-called Huo-Yan COVID-19 testing labs in Saudi Arabia, based on the emergency lab the firm set up in Wuhan, China in February.
A Nature survey finds a high level of support among scientists for former Vice President Joe Biden in the upcoming US election.
Two coronavirus vaccine trials that had been paused in the US have resumed.
The Scientist reports the physician behind Surgisphere inactivated his medical license in one state and received one in another.
In PLOS this week: analysis of link between somatic copy number and telomere length, sequencing study of individuals with gallbladder S. Typhi colonization, and more.